Cancer Research: Selected Federal Spending and Morbidity and Mortality Statistics

Order Code 96-253 SPR Updated April 28, 2008 Cancer Research: Selected Federal Spending and Morbidity and Mortality Statistics Judith A. Johnson Domestic Social Policy Division Janet Kinzer Knowledge Services Group Table 1 shows federal spending at the National Institutes of Health (NIH) for research on selected cancer sites (i.e., the part of the body in which the cancer presents itself). Most cancer research at NIH is conducted by the National Cancer Institute (NCI); NCI amounts are indicated in parentheses (which are a subset of the number above it). The estimate for FY2009 is based on the President’s request. Table 1. NIH Research Funding for Selected Cancer Sites ($ in millions; NCI portion of NIH total is shown in parentheses) Cancer Breast Cervical Colorectal Lung Ovarian Prostate Uterine NIH total (NCI total) FY2004 Actual $708 (566) 94 (79) 297 (262) 297 (273) 112 (100) 378 (309) 35 (27) $5,547 ($4,723) FY2005 FY2006 Actual Actual $700 $718 (560) (585) 96 97 (82) (83) 284 269 (253) (244) 289 266 (266) (243) 106 102 (98) (95) 373 348 (309) (293) 39 28 (31) (19) $5,639 $5,575 ($4,795) ($4,747) FY2007 FY2008 FY2009 Actual Estimate Estimate $707 $705 $703 (572) (572) (572) 96 96 96 (82) (82) (82) 282 282 282 (258) (258) (258) 249 249 249 (227) (227) (227) 103 103 103 (97) (97) (97) 345 344 344 (296) (296) (296) 22 22 22 (17) (17) (17) $5,643 $5,652 $5,654 ($4,795) ($4,805) ($4,810) Source: NIH budget office, February 5, 2008, and NCI budget office, April 24, 2008. Note: Amounts for the cancer sites do not add up to the totals. In addition to funding research on many other cancer sites, NIH supports basic cancer research on prevention, epidemiology, carcinogenesis, tumor biology, immunology, as well as research on diagnosis and treatment of cancer patients. CRS-2 In the past, federal cancer research was conducted solely by NIH. In FY1992, Congress appropriated $25 million for breast cancer research to the Department of Defense (DOD). In FY1997, Congress began providing for research on ovarian and prostate cancer as well. Table 2 shows appropriations for these cancers for the past seven years. Funding for DOD cancer research does not appear in the Administration’s budget, but rather originates with Congress as part of the appropriations process. On November 13, 2007, the Department of Defense Appropriations Act of 2008 was signed into law (P.L. 110-116). A total of $228 million was made available in FY2008 for peer-reviewed cancer research on breast ($138 million), ovarian ($10 million), and prostate cancer ($80 million). Table 2. Congressional Appropriations to DOD for Cancer Research ($ in millions) Cancer Breast Ovarian Prostate FY2002 FY2003 $150 $150 10.2 10 85 85 FY2004 $150 10 85 FY2005 FY2006 FY2007 FY2008 $150 $127.5 $127.5 $138 10 10 10 10 85 80 80 80 Source: DOD Appropriation documents and H.Rept. 110-434. Note: More about the DOD Congressionally Directed Medical Research Program is at [http://cdmrp.army.mil/]. Table 3 gives estimates for the number of new cancer cases and deaths expected in 2008 for selected sites. Annual estimates of cancer cases and deaths are published by the American Cancer Society based on incidence rates obtained from NCI’s Surveillance, Epidemiology, and End Results (SEER) program, which collects data from cancer registries in various parts of the country, representing about 10% of the U.S. population. Table 3. Estimated U.S. Cancer Cases and Deaths — Selected Sites, 2008 Cancer Breast (female) Cervical Colorectal Lung Ovarian Prostate Uterine All cancer sitesa Cases 182,460 11,070 148,810 215,020 21,650 186,320 40,100 1,437,180 Deaths 40,480 3,870 49,960 161,840 15,520 28,660 7,470 565,650 Source: A. Jemal, et al., Cancer Statistics, 2008. CA — A Cancer Journal for Clinicians, vol. 58, March/April 2008, at [http://caonline.amcancersoc.org/cgi/reprint/58/2/71]. a. Totals for all cancer sites include those listed in Table 3 and other cancer sites not listed here.